丹望医疗科技（上海）有限公司，是国内领先的专注类器官技术的平台型公司。公司致力于采用最先进的类器官技术，为临床科研和药物研发提供优质的类器官模型及相关服务。 公司十分重视新技术的研发、创新成果的转化。目前，公司获得国家高新技术企业、科技型中小企业、专精特新中小企业认定； 药物研发服务平台入选上海市2022年度“科技创新行动计划”专业技术服务平台建设项目。 未来，丹望医疗将持续加大类器官技术攻关，提高技术创新能力水平，更好地惠及医疗健康领域及人民群众健康。D1 Medical Technology (Shanghai) Co., Ltd. aspired to be the leader in the development of organoid technology that covering three key commercial sections: precision oncology, basic medical research and drug discovery. Our state-of-the-art technology enables basic medical scientists and drug researchers to acquire accurate, efficient and high-standard organoids and services, including clinical candidates validation, drug toxicity evaluation, disease modeling, etc.With the mission of being a company of "let personalized medicine benefit every patient"，we aim to promote human medical development and deliver superior solutions for scientific research and drug development by organoid technology in vitro. [详细介绍]